Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1199P is a pseudogene of the U6 small nuclear RNA gene, one of many U6-derived pseudogenes in the human genome[3][5]. The U6 snRNA is an essential non-coding RNA involved in the catalytic core of the spliceosome, where it is crucial for pre-mRNA splicing[1][3]. However, pseudogenes like RNU6-1199P are defined as non-functional copies of coding or non-coding genes that arise during evolution through duplication or retrotransposition followed by disabling mutations[4][5]. These copies are typically not expressed or translated into functional products; instead, they may bear sequence similarity to parental genes but have lost their original purpose[4][5][6]. A 1985 analysis of U6 snRNA pseudogenes in human DNA found novel structures with direct repeats and significant similarity (77%) to genuine U6 RNA sequences, but retaining mutations or structural differences that render them inactive[5]. Numerous U6 pseudogenes are present in vertebrate genomes, possibly reflecting evolutionary processes[3][5]. There is no evidence that RNU6-1199P or similar pseudogenes serve as drug targets or have utility in biomarker development or disease monitoring.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1199, pseudogene (RNU6-1199P).